This web site is brought to you by
- BioTD, Bio Technology Developers (www.biotd.net) , manufacturer of Citofem.
- BioDis (www.biodisglobal.com) , Bio Technology Distributors, a division of Falcon Management Group. BioDis is the exclusive distributor Citofem in United States, Asia, Africa and the Middle East.
Feedback
In an effort to continually improve our site and the information we provide, we would like to know if our site was helpful to you. We would also like to know what other information we can provide to further help you. Please give us your feedback.
We’d also like to know if you visited your healthcare provider recently and asked for the Citofem based test. If so, was the Citofem based test ordered for you? Please share your experience with us.
You can also follow us on
Twitter - @CitofemGlobal
FaceBook- facebook.com/BioDisUSA
In processing, the samples are concentrated, preserving the cells and removing many of the contaminants, such as mucus and inflammation. Then the concentrated cells are removed and preserved, requiring a small amount of the collected cells for initial testing. This allows for multiple tests to be run of a single collection sample. 
Advanced screening techniques ranging from cell collection to analysis make Citofem® a great choice for modern cervical cancer screening. 
In the fight against cervical cancer, there are many clear advantages to using Liquid Based Cytology (LBC) as the primary screening tool. LBC is quality and affordable product which is easy to use for for patients, medical professionals and laboratory workers. The testing materials, combined with no ancillary fees in terms of additional equipment requirements, make Citofem an affordable choice.